Related Experiment Video
Updated: Jun 24, 2026

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells
Published on: August 7, 2017
The use of stem cells in kidney disease
Preeti Chhabra1, Kenneth L Brayman
1Department of Surgery, University of Virginia, Health Sciences Center, Charlottesville, Virginia 22908, USA.
Purpose Of Review:
Acute and chronic kidney disease is a leading cause of morbidity and mortality worldwide with overall mortality rates between 50 and 80%. An acute shortage of compatible organs coupled with limited adaptability of current dialysis techniques has created a sense of urgency to investigate new alternatives, and the purpose of this review is to provide a concise overview of current stem cell-based strategies in renal repair following acute kidney injury.
Recent Findings:
Bone marrow-derived mesenchymal stem cells hold therapeutic potential in repairing tubular injury, ameliorating renal function deficits, and prolonging survival in experimental models of acute kidney injury. These renoprotective effects are mediated mainly by paracrine mechanisms that act on surviving tubular cells by stimulating dedifferentiation, proliferation, migration, and eventually redifferentiation into mature epithelial cells as well as by stimulating expansion and differentiation of resident stem/progenitor cells. Mesenchymal stem cells are capable of immunosuppression as well as inducing protection against peritubular capillary changes following acute injury making them ideal for allogeneic cell therapy.
Summary:
Autologous transplantation of bone marrow-derived mesenchymal stem cells as well as adult renal stem/progenitor cells that can be easily harvested and expanded may be the solution to limited donor organ availability and chronic immunosuppressive therapy.
Insights
Mesenchymal stem cells show promise for acute kidney injury repair by promoting tubular regeneration and reducing inflammation. Autologous stem cell therapy offers a potential solution to donor organ shortages and the need for long-term immunosuppression.
Area of Science:
- Nephrology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Kidney disease is a major global health concern with high mortality rates.
- Limited organ availability and dialysis limitations necessitate novel therapeutic strategies.
- Acute kidney injury (AKI) requires effective regenerative approaches.
Purpose of the Study:
- To review current stem cell-based strategies for renal repair in AKI.
- To highlight the therapeutic potential of mesenchymal stem cells in kidney regeneration.
Main Methods:
- Review of experimental models of AKI.
- Analysis of bone marrow-derived mesenchymal stem cells (MSCs) and adult renal stem/progenitor cells.
- Investigation of paracrine mechanisms and immunomodulatory effects of MSCs.
Main Results:
- MSCs demonstrate therapeutic potential in AKI models, repairing tubular injury and improving renal function.
- Renoprotective effects are mediated by paracrine signaling, stimulating tubular cell regeneration and resident stem cell activity.
- MSCs exhibit immunosuppressive properties and protect against microvascular injury, supporting allogeneic transplantation.
Conclusions:
- Autologous transplantation of MSCs and adult renal stem/progenitor cells is a promising strategy for AKI.
- Stem cell therapy may overcome limitations of donor organ scarcity and reduce the need for chronic immunosuppression.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Kidney Transplant I: Introduction
Stem Cell Culture
iPS Cell Differentiation
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention

